Kevin Roberts

This inventor holds 11 USPTO granted patents and 11 published patent applications and 3 EPO patents. Top assignees: Sorriso Pharmaceuticals, Inc., Vhsquared Limited. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Roberts. Retrieved from https://idiyas.com/inventor/kevin-roberts-g1bapssg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 11)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 29(Granted Patents)

Location History:

Babraham, GB (2021 - 2022)
Cambridge, GB (2020 - 2023)

Company Filing History:

8 out of 10

Sorriso Pharmaceuticals, Inc.

Years Active: 2020-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12247079 - Polynucleotides encoding, and method of making, a polypeptide comprising a VHH which binds interleukin-receptor (IL-7R) (2025-03-11),

2. 12234279 - Peptide construct having a protease-cleavable linker (2025-02-25),

3. 12173054 - Polypeptides (2024-12-24),

4. 12098197 - Polypeptides comprising immunoglobulin chain variable domains which bind to interleukin-6 receptor (IL-6R) and methods of use thereof to treat autoimmune and inflammatory diseases (2024-09-24),

5. 11684677 - Compositions (2023-06-27),

6. 11667719 - VHH immunoglobulin chain variable domain that binds to IL-7R and methods of use thereof for treating autoimmune and/or inflammatory diseases (2023-06-06),

7. 11623952 - IL-23 and TNF-alpha binding bi-specific heavy chain polypeptides (2023-04-11),

8. 11401327 - Polypeptides which bind to interleukin-6 receptor (IL-6R) (2022-08-02),

9. 10980748 - Compositions (2021-04-20),

10. 10772839 - Compositions (2020-09-15),

11. 10633438 - Polypeptides (2020-04-28),

Title: Kevin Roberts: Innovator in Biopharmaceuticals

Introduction

Kevin Roberts is a notable inventor based in Babraham, GB. He has made significant contributions to the field of biopharmaceuticals, holding a total of 11 patents. His work focuses on innovative solutions that address critical medical needs.

Latest Patents

Among his latest patents is a groundbreaking invention related to polynucleotides encoding and methods for creating polypeptides that bind to the interleukin-receptor (IL-7R). This invention provides polypeptides capable of inhibiting IL-7 and/or L-TSLP binding to IL-7R, along with constructs and pharmaceutical compositions that incorporate these polypeptides. Another notable patent involves a peptide construct featuring a protease-cleavable linker. This construct is designed for oral administration and consists of two polypeptides connected by a labile peptide linker, which is sensitive to proteases present in the intestinal tract, while the polypeptides themselves remain resistant to these enzymes.

Career Highlights

Kevin has worked with several companies throughout his career, including Sorriso Pharmaceuticals, Inc. and Vhsquared Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in the biopharmaceutical sector.

Collaborations

Throughout his career, Kevin has collaborated with notable professionals in the field, including Scott Crowe and Mike West. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kevin Roberts stands out as an influential inventor in the biopharmaceutical industry, with a strong portfolio of patents that reflect his commitment to innovation. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.